Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial
DiscussionThe MIDEX MRI study will assess the efficacy of intranasal dexmedetomidine compared to oral midazolam to improve the quality of a propofol-based sedation prior to magnetic resonance imaging, without negative repercussion on the postoperative period.Trial registrationClinicalTrial.govNCT05192629. Registered on 14 January 2022. Protocol version 2.1
Source: Trials - Category: Research Source Type: clinical trials
More News: Anesthesia | Anesthesiology | Anxiety | Children | Clinical Trials | Diprivan | MRI Scan | Pediatrics | Propofol | Research | Statistics | Study